Breast cancer is classified into three major therapeutic subtypes: estrogen and/or progesterone receptor-positive (ER+, PR+), HER2+, and triple-negative breast cancer (TNBC) (lacking expression of ER, PR, and HER2) [3,4]. The gene discussed is ERBB2; the disease is breast cancer.